Table 7.
Cell cycle phase distribution following transfection of SKOV3 cells
| Group | Cell ratios, % | P-value | |||
|---|---|---|---|---|---|
|
| |||||
| G0-G1 | S | G2-M | S+G2+M | ||
| SKOV3 | 72.9 ± 23.3 | 24.2 ± 3.7 | 2.83 ± 0.8 | 27.1 ± 4.8 | - |
| SKOV3-pEGFP-N1 | 73.0 ± 20.4 | 22.1 ± 4.9 | 4.86 ± 0.7 | 27.0 ± 4.6 | 0.378a |
| SKOV3-CCL18-pEGFP-N1 | 67.2 ± 18.7 | 27.8 ± 4.3 | 5.01 ± 0.9 | 32.8 ± 4.4 | 0.022a |
| SKOV3-pSilencer4.1-CCL18-siRNA127 | 80.3 ± 17.9 | 18.0 ± 5.9 | 1.69 ± 0.6 | 19.7 ± 4.4 | 0.015a |
| KOV3-pSilencer4.1 | 71.0 ± 20.7 | 25.1 ± 6.0 | 3.94 ± 0.7 | 29.0 ± 6.1 | 0.265a |
Values are provided as the mean percentage ± standard deviation, and compared by one-way analysis of variance.
a
SKOV3 group vs. other groups.
CCL18, chemokine ligand 18.